Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 2491 AL 2505

Loss of Calbindin immunoreactivity in the dentate gyrus distinguishes Alzheimer's disease from other neurodegenerative dementias

Stefanits H, Wesseling C, Kovacs GG.

Neurosci Lett. 2014 Apr 30;566:137-41. doi: 10.1016/j.neulet.2014.02.026. Epub 2014 Feb 23.

Susceptibility-weighted imaging changes suggesting brain iron accumulation in Huntington's disease: an epiphenomenon which causes diagnostic difficulty

Macerollo A, Perry R, Stamelou M, Batla A, Mazumder AA, Adams ME, Bhatia KP.

Eur J Neurol. 2014 Feb;21(2):e16-7. doi: 10.1111/ene.12298.

Prospects for neuroprotective therapies in prodromal Huntington's disease

Chandra A, Johri A, Beal MF.

Mov Disord. 2014 Mar;29(3):285-93. doi: 10.1002/mds.25835. Epub 2014 Feb 26.

Acute psychosis in a verified Huntington disease gene carrier with subtle motor signs: psychiatric criteria should be considered for the diagnosis

Nagel M, Rumpf HJ, Kasten M.

Gen Hosp Psychiatry. 2014 May-Jun;36(3):361.e3-4. doi: 10.1016/j.genhosppsych.2014.01.008. Epub 2014 Jan 25.

Lipid integration in neurodegeneration: an overview of Alzheimer's disease

Yadav RS, Tiwari NK.

Mol Neurobiol. 2014 Aug;50(1):168-76. doi: 10.1007/s12035-014-8661-5. Epub 2014 Mar 5.

Morphological and bioenergetic demands underlying the mitophagy in post-mitotic neurons: the pink-parkin pathway

Amadoro G, Corsetti V, Florenzano F, Atlante A, Bobba A, Nicolin V, Nori SL, Calissano P.

Front Aging Neurosci. 2014 Feb 18;6:18. doi: 10.3389/fnagi.2014.00018. eCollection 2014.

Lower limb monochorea from a globus pallidus infarct

Pandey S, Gupta S.

J Clin Neurosci. 2014 Aug;21(8):1455-7. doi: 10.1016/j.jocn.2013.10.038. Epub 2014 Feb 3.

Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease

Sepers MD, Raymond LA.

Drug Discov Today. 2014 Jul;19(7):990-6. doi: 10.1016/j.drudis.2014.02.006. Epub 2014 Mar 3.

Cholesterol homeostasis failure in the brain: implications for synaptic dysfunction and cognitive decline

Segatto M, Leboffe L, Trapani L, Pallottini V.

Curr Med Chem. 2014;21(24):2788-802. doi: 10.2174/0929867321666140303142902.

Huntington disease: natural history, biomarkers and prospects for therapeutics

Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ.

Nat Rev Neurol. 2014 Apr;10(4):204-16. doi: 10.1038/nrneurol.2014.24. Epub 2014 Mar 11.

Dexmedetomidine for postoperative Huntington's chorea

Matsunami S, Komasawa N, Minami T.

J Anesth. 2014 Oct;28(5):798. doi: 10.1007/s00540-014-1813-y. Epub 2014 Mar 13.

Abnormal red cell features associated with hereditary neurodegenerative disorders: the neuroacanthocytosis syndromes

De Franceschi L, Bosman GJ, Mohandas N.

Curr Opin Hematol. 2014 May;21(3):201-9. doi: 10.1097/MOH.0000000000000035.

Cell-based therapies for Huntington's disease

Chen Y, Carter RL, Cho IK, Chan AW.

Drug Discov Today. 2014 Jul;19(7):980-4. doi: 10.1016/j.drudis.2014.02.012. Epub 2014 Mar 12.

The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy

Cortes CJ, La Spada AR.

Drug Discov Today. 2014 Jul;19(7):963-71. doi: 10.1016/j.drudis.2014.02.014. Epub 2014 Mar 13.

Biomarker development for Huntington's disease

Andre R, Scahill RI, Haider S, Tabrizi SJ.

Drug Discov Today. 2014 Jul;19(7):972-9. doi: 10.1016/j.drudis.2014.03.002. Epub 2014 Mar 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias